Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reynoutria japonica aqueous extract is a **botanical extract drug candidate and traditional medicine-derived preparation** obtained from the dried roots and rhizomes of *Reynoutria japonica* Houtt. It is a complex multicomponent mixture rather than a single defined molecular entity, with reported constituents including anthraquinones such as emodin, stilbenes such as polydatin and resveratrol, and flavonoids. Preclinical studies, including a mouse study in ulcerative colitis, suggest that its pharmacology is pleiotropic and may involve modulation of gut microbiota composition and metabolism, reduction of inflammatory signaling, restoration of intestinal mucosal integrity, and increased short-chain fatty acid production. Based on the provided evidence, it appears to be an investigational research extract used in preclinical and traditional medicine contexts rather than a commercially developed pharmaceutical product with a clearly identified sponsor, brand, single target, or established regulatory approval pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on reynoutria japonica aqueous extract.